“You may have to switch from a compounded GLP-1 to the manufactured version, because the manufactured versions aren’t in shortage anymore,” says Stacia Woodcock, PharmD, Pharmacy Editor at GoodRx. In this video, learn what to expect when making the switch from a compounded GLP-1 to a branded version, such as Ozempic, Wegovy, Mounjaro, and Zepbound.
Stacia Woodcock, PharmD, is a pharmacy editor for GoodRx. She earned her Doctor of Pharmacy degree from the University of Kentucky and is licensed in New York and Massachusetts.
References
NovoCare. (n.d.). Ways to save on Wegovy.
U.S. Food and Drug Administration. (2024). FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products.
U.S. Food and Drug Administration. (2025). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize.
Why trust our experts?


Search and compare options









